Event: PHARM Connect Congress
Date: 10-11 March 2020
Location: Online Conference
Case Study Presentation: Functional HPMC-based Capsules for both Oral Dosage Forms and Dry-powder Inhalation
Presenter: Frédérique Bordes-Picard, Business Development Manager, Lonza
Presentation Details: Tuesday, 10 March 2020, 10:40 AM - 11:20 AM
PHARM Connect Congress is the largest and most important pharmaceutical and biotechnology business summit in the Central Eastern European region. With over 500 participants from over 25 countries in the region and beyond, PHARM Connect Congress is a great platform to benchmark and network with an exclusive group of industry cohorts.
Lonza designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health & nutrition industries. Our unique combination of science, engineering, formulation and capsule expertise enables our customers to optimize the bioavailability, targeted delivery and overall performance of our biopharmaceutical and consumer health & nutrition products.
Learn more about the benefits of HPMC-based capsules for both oral dosage forms and dry-powder inhalation in a Case Study Presentation from Frédérique Bordes-Picard.